Quick Summary
This study compared long-term effects of COVID-19 infection (long-COVID) with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to see how similar they are. Researchers found that many people who develop long-COVID experience the same symptoms as ME/CFS patients, including severe fatigue, brain fog, headaches, and worsening of symptoms after physical activity. The study suggests that COVID-19 may trigger a ME/CFS-like condition in some people through inflammatory processes in the body.
Why It Matters
This study is important because it formally documents the clinical and mechanistic similarities between long-COVID and ME/CFS, potentially helping clinicians recognize and diagnose ME/CFS-like conditions in COVID-19 survivors. Understanding this overlap may accelerate research into shared pathological pathways, such as persistent inflammation and immune dysregulation, which could benefit both patient populations. The recognition of post-COVID-19 condition by the WHO as a distinct entity strengthens the case for ME/CFS research and legitimacy.
Observed Findings
What the study reports it measured.
- Considerable overlap exists between post-COVID-19 condition symptomatology and ME/CFS in onset, progression, and symptom profiles.
- A debilitating syndrome can emerge approximately three months post-COVID-19 infection, characterized by fatigue, headache, cognitive dysfunction, post-exertional malaise, orthostatic intolerance, and dyspnea.
- Acute inflammation, oxidative stress, and elevated interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) levels are reported in SARS-CoV-2 infected patients.
- COVID-19 produces multi-system adverse effects including nervous, cardiovascular, gastrointestinal/metabolic, and immune system complications.
Inferred Conclusions
What the authors interpret from those results.
- Post-COVID-19 condition represents a distinct WHO-recognized clinical entity with substantial phenotypic overlap to ME/CFS.
- The wide-ranging pro-inflammatory effects of SARS-CoV-2 may explain the development of post-COVID-19 clinical complications in a proportion of infected individuals.
- Longitudinal monitoring of post-COVID-19 patients is necessary to understand long-term effects and establish pathomechanisms underlying persistent symptoms.
Remaining Questions
- What is the exact prevalence of ME/CFS-like illness in COVID-19 survivors, and are there identifiable risk factors for developing post-COVID-19 condition versus recovery?
- Do post-COVID-19 condition and ME/CFS share identical pathomechanisms, or are the clinical similarities masking distinct underlying pathophysiologies?
- What role do persistent viral reservoirs, viral proteins, or reactivation of latent pathogens play in sustaining inflammation in post-COVID-19 condition?
- Can biomarkers of inflammation and oxidative stress predict long-term outcomes and differentiate post-COVID-19 condition from other chronic fatigue etiologies?
What This Study Does Not Prove
This systematic review does not establish that COVID-19 infection directly causes ME/CFS, only that symptom overlap exists—correlation is not causation. The study does not provide definitive prevalence rates of how many COVID-19 patients develop ME/CFS-like illness or confirm mechanistic causality. It also does not establish whether post-COVID-19 condition and ME/CFS share identical underlying pathophysiology versus appearing similar clinically while having different etiologies.
Explore further
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Cite this study
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Sukocheva, Olga A, Maksoud, Rebekah, Beeraka, Narasimha M, Madhunapantula, SabbaRao V, Sinelnikov, Mikhail, Nikolenko, Vladimir N, et al. (2022). Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.. Journal of advanced research. https://doi.org/10.1016/j.jare.2021.11.013
BibTeX
@article{mecfsatlas-sukocheva-2022-analysis-post,
author = {Sukocheva, Olga A and Maksoud, Rebekah and Beeraka, Narasimha M and Madhunapantula, SabbaRao V and Sinelnikov, Mikhail and Nikolenko, Vladimir N and Neganova, Margarita E and Klochkov, Sergey G and Amjad Kamal, Mohammad and Staines, Donald R and Marshall-Gradisnik, Sonya},
title = {Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.},
journal = {Journal of advanced research},
year = {2022},
doi = {10.1016/j.jare.2021.11.013},
note = {PubMed: 36100326},
url = {https://www.mecfsatlas.com/evidence/sukocheva-2022-analysis-post},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-14. https://www.mecfsatlas.com/evidence/sukocheva-2022-analysis-post
Contribute
Private, reviewed by a human. Not a public comment thread.